{"id":6418,"date":"2021-03-10T21:52:46","date_gmt":"2021-03-11T05:52:46","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=6418"},"modified":"2021-03-10T21:52:46","modified_gmt":"2021-03-11T05:52:46","slug":"sars-cov-2-antibody-prevalence-in-patients-on-dialysis-in-the-us-in-january-2021","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/03\/10\/sars-cov-2-antibody-prevalence-in-patients-on-dialysis-in-the-us-in-january-2021\/","title":{"rendered":"SARS-COV-2 Antibody Prevalence in Patients on Dialysis in the US in January 2021"},"content":{"rendered":"<ul>\n<li><i>[Pre-print, not peer-reviewed]<\/i> A cross-sectional assessment of SARS-CoV-2 seroprevalence among patients in the US receiving dialysis (n = 21,424) in January 2021 with the goal of estimating the seroprevalence in the general US adult population found that seroprevalence was 18.9% in the study sample, which translated to an estimated 18.7% in the US dialysis population, and 21.3% in the US adult population. Patients in the sample were disproportionately older and from minority race\/ethnic groups. Younger people (18-44 years), those self-identifying as Hispanic or living in Hispanic neighborhoods, and those living in the poorest neighborhoods were among the subgroups with the highest seroprevalence (25.9%, 25.1%, 24.8%, respectively). Compared to data from July 2020, there was diminished variability in seroprevalence by geographic region and urban-rural status.<span class=\"Apple-converted-space\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i>Anand et al.\u00a0(Mar 9, 2021). SARS-COV-2 Antibody Prevalence in Patients on Dialysis in the US in January 2021. Pre-print downloaded Mar 10 from <\/i><a href=\"https:\/\/doi.org\/10.1101\/2021.03.07.21252786\">https:\/\/doi.org\/10.1101\/2021.03.07.21252786<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[Pre-print, not peer-reviewed] A cross-sectional assessment of SARS-CoV-2 seroprevalence among patients in the US receiving dialysis (n = 21,424) in January 2021 with the goal of estimating the seroprevalence in the general US adult population found that seroprevalence was 18.9% in the study sample, which translated to an estimated 18.7% in the US dialysis population,&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/03\/10\/sars-cov-2-antibody-prevalence-in-patients-on-dialysis-in-the-us-in-january-2021\/\">Read more<\/a><\/div>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[42,29],"topic":[16],"class_list":["post-6418","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-disparities","tag-public-health","topic-public-health-policy-and-practice"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=6418"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6418\/revisions"}],"predecessor-version":[{"id":6419,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6418\/revisions\/6419"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=6418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=6418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=6418"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=6418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}